235 related articles for article (PubMed ID: 17040264)
1. Expression of adhesion molecules in atopic dermatitis is reduced by tacrolimus, but not by hydrocortisone butyrate: a randomized immunohistochemical study.
Caproni M; Torchia D; Antiga E; Volpi W; Fabbri P
Clin Exp Dermatol; 2006 Nov; 31(6):813-7. PubMed ID: 17040264
[TBL] [Abstract][Full Text] [Related]
2. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study.
Caproni M; Torchia D; Antiga E; Terranova M; Volpi W; del Bianco E; D'Agata A; Fabbri P
Br J Dermatol; 2007 Feb; 156(2):312-9. PubMed ID: 17223872
[TBL] [Abstract][Full Text] [Related]
3. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
4. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis.
Antiga E; Volpi W; Torchia D; Fabbri P; Caproni M
Clin Exp Dermatol; 2011 Apr; 36(3):235-41. PubMed ID: 21070333
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecules in atopic dermatitis: VCAM-1 and ICAM-1 expression is increased in healthy-appearing skin.
Jung K; Linse F; Heller R; Moths C; Goebel R; Neumann C
Allergy; 1996 Jul; 51(7):452-60. PubMed ID: 8863922
[TBL] [Abstract][Full Text] [Related]
6. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
7. Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy.
Dahlman-Ghozlan K; Ortonne JP; Heilborn JD; Stephansson E
Exp Dermatol; 2004 Feb; 13(2):65-9. PubMed ID: 15009098
[TBL] [Abstract][Full Text] [Related]
8. A study of the kinetics and pattern of E-selectin, VCAM-1 and ICAM-1 expression in chronic actinic dermatitis.
Menagé Hdu P; Sattar NK; Haskard DO; Hawk JL; Breathnach SM
Br J Dermatol; 1996 Feb; 134(2):262-8. PubMed ID: 8746339
[TBL] [Abstract][Full Text] [Related]
9. The role of adhesion molecules in atopic dermatitis.
Lugović L; Cupić H; Lipozencić J; Jakić-Razumović J
Acta Dermatovenerol Croat; 2006; 14(1):2-7. PubMed ID: 16603095
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
[TBL] [Abstract][Full Text] [Related]
11. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
12. A study to determine the effect of tacrolimus on ceramide levels in the stratum corneum of patients with atopic dermatitis.
Paslin D; Wertz P
Int J Dermatol; 2006 Apr; 45(4):352-6. PubMed ID: 16650156
[TBL] [Abstract][Full Text] [Related]
13. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients.
Pestelli E; Floriani I; Fabbri P; Caproni M
Int J Tissue React; 2003; 25(1):1-8. PubMed ID: 12854881
[TBL] [Abstract][Full Text] [Related]
14. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E;
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173
[TBL] [Abstract][Full Text] [Related]
18. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
Kim HO; Lee CH; Ahn HK; Park CW
Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
[TBL] [Abstract][Full Text] [Related]
19. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.
Bensignor E; Olivry T
Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106
[TBL] [Abstract][Full Text] [Related]
20. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
